Important Message: Beware of Impersonation Scams

Fraudulent messages and advertisements are currently circulating on messaging platforms, including WhatsApp, impersonating Candriam’s brand and investment professionals. Please note that Candriam never offers investment recommendations or provides financial advice through social media channels or messaging platforms.

Brand Values: Unravelling Luxury Goods Risks

What’s behind a name? 

If brand value is image, reputation, and a track record of quality, the higher the price of the product, the more important that image is for pricing and profit. And the more susceptible to negative news which might affect that image

 

Supply chain risk management remains particularly complex and opaque in sectors such as luxury brands.

Supply chain management is a core determinant of long-term resilience. It shapes operational risk, cost structures and exposure to reputational and legal challenges. Globalisation brought efficiency but, as Covid-19 demonstrated, globalisation brought systemic fragility and a frightening level of opaqueness.

Imagine the difficulty of a luxury goods manufacturer in documenting its supply chain. Beyond the first-level supplier, they have little or no visibility.

 

What are luxury goods companies doing about this?

We are engaging with several companies in the luxury goods industry to better understand how they are strengthening their supply chain due diligence. Ben Chekroun, Lead ESG Analyst – Engagement, answers our questions. 

Read the interview

;
Emma Miguel Unzue
ESG Analyst
Supply chain transparency has become a prerequisite for maintaining brand image and competitiveness in the luxury sector.

What does this mean for investors in luxury goods companies?

  • Luxury goods rely on image. For many, that image includes sustainability. Just look at some of the ‘sustainability’ pages on their websites.
  • Yet paradoxically because of that immaculate image, consumers take ethical sourcing for granted, amplifying the brand value damage when a human rights violation is arises and is made public.
  • With EU regulations coming into force in stages, traceability is possibly an even greater headache. Reputational risk through news headlines can mean swift and sharp shocks to brand and shareholder value.
white paper

There’s more on analysing this lurking risk in our new white paper on Luxury Goods supply chains

Human Rights in the Food Supply Chain

Other industries also have complex and opaque supply chains. We have also shared out Find a framework for analysing supply chains in the food industry 

Cultivating Human Rights in the Food Supply Chain

Latest analyses

  • Research Paper, Lucia Meloni, Emma Miguel Unzue, ESG, SRI

    Brand Values: Unravelling Luxury Goods Risks

    If brand value is image, reputation, and a track record of quality, the higher the price of the product, the more important that image is for pricing and profit. And the more susceptible to negative news which might affect that image.
  • Research Paper, ESG, SRI, Marie Niemczyk, Benjamin Manent-Manent

    The Forest We Ate: How Agriculture Consumes Biodiversity

    The loss of biodiversity has financial and investment implications. While not-for-profits and investors such as ourselves are straining to actually quantify our risks, the qualitative indicators are mounting.
  • Research Paper, Alix Chosson, Elouan Heurard, ESG, SRI, Biodiversity

    Can We Assess Companies’ Ecological Debt? And How?

    While, according to the World Economic Forum, half of the global GDP is dependent on nature, biodiversity is experiencing an extinction that challenges the resilience of our economies. Deterioration of air, water and soil quality, decline in ecosystem services such as pollination: the physical impacts of this loss of biodiversity are already putting our economies under pressure.
  • Healthcare, ESG, SRI

    Why healthcare, why now?

    On Tuesday, September 30, the pharmaceutical industry issued its first formal response to President Trump’s recent letter on drug pricing, announcing a deal between Pfizer and the US administration.

Find it fast

Get information faster with a single click

Get insights straight to your inbox